BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 38430129)

  • 1. Whodunit? The Contribution of Interleukin (IL)-17/IL-22-Producing γδ T Cells, αβ T Cells, and Innate Lymphoid Cells to the Pathogenesis of Spondyloarthritis.
    Reinhardt A; Prinz I
    Front Immunol; 2018; 9():885. PubMed ID: 29922283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance of antigen-presenting cells by CD4+ CD25+ regulatory T cells in autoimmunity: immunopathogenesis and therapeutic implications.
    André S; Tough DF; Lacroix-Desmazes S; Kaveri SV; Bayry J
    Am J Pathol; 2009 May; 174(5):1575-87. PubMed ID: 19349365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-2-induced skin inflammation.
    Sommer C; Cohen JN; Dehmel S; Neuhaus V; Schaudien D; Braun A; Sewald K; Rosenblum MD
    Eur J Immunol; 2024 Apr; 54(4):e2350580. PubMed ID: 38430129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-38 protects against sepsis by augmenting immunosuppressive activity of CD4
    Ge Y; Huang M; Wu Y; Dong N; Yao YM
    J Cell Mol Med; 2020 Jan; 24(2):2027-2039. PubMed ID: 31880383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuning IL-2 signaling by ADP-ribosylation of CD25.
    Teege S; Hann A; Miksiewicz M; MacMillan C; Rissiek B; Buck F; Menzel S; Nissen M; Bannas P; Haag F; Boyer O; Seman M; Adriouch S; Koch-Nolte F
    Sci Rep; 2015 Mar; 5():8959. PubMed ID: 25753532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4
    Yan JJ; Lee JG; Jang JY; Koo TY; Ahn C; Yang J
    Kidney Int; 2017 Mar; 91(3):603-615. PubMed ID: 27914701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium falciparum-mediated induction of human CD25Foxp3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta.
    Scholzen A; Mittag D; Rogerson SJ; Cooke BM; Plebanski M
    PLoS Pathog; 2009 Aug; 5(8):e1000543. PubMed ID: 19680449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T cells in skin mediate immune privilege of the hair follicle stem cell niche.
    Cohen JN; Gouirand V; Macon CE; Lowe MM; Boothby IC; Moreau JM; Gratz IK; Stoecklinger A; Weaver CT; Sharpe AH; Ricardo-Gonzalez RR; Rosenblum MD
    Sci Immunol; 2024 Jan; 9(91):eadh0152. PubMed ID: 38181095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2-based approaches to Treg enhancement.
    Harris F; Berdugo YA; Tree T
    Clin Exp Immunol; 2023 Mar; 211(2):149-163. PubMed ID: 36399073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2-based therapies in cancer.
    Raeber ME; Sahin D; Boyman O
    Sci Transl Med; 2022 Nov; 14(670):eabo5409. PubMed ID: 36350987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TransCon IL-2 β/γ: a novel long-acting prodrug with sustained release of an IL-2Rβ/γ-selective IL-2 variant with improved pharmacokinetics and potent activation of cytotoxic immune cells for the treatment of cancer.
    Rosen DB; Kvarnhammar AM; Laufer B; Knappe T; Karlsson JJ; Hong E; Lee YC; Thakar D; Zúñiga LA; Bang K; Sabharwal SS; Uppal K; Olling JD; Kjaergaard K; Kurpiers T; Schnabel M; Reich D; Glock P; Zettler J; Krusch M; Bernhard A; Heinig S; Konjik V; Wegge T; Hehn Y; Killian S; Viet L; Runz J; Faltinger F; Tabrizi M; Abel KL; Breinholt VM; Singel SM; Sprogøe K; Punnonen J
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35817480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine-tuned long-acting interleukin-2 superkine potentiates durable immune responses in mice and non-human primate.
    Merchant R; Galligan C; Munegowda MA; Pearce LB; Lloyd P; Smith P; Merchant F; To MD
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35058325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group 2 innate lymphoid cells (ILC2s) are important in typical type 2 immune-mediated diseases and an essential therapeutic target.
    Jin J; Sunusi S; Lu H
    J Int Med Res; 2022 Jan; 50(1):3000605211053156. PubMed ID: 35048721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma Delta T Cells and Their Pathogenic Role in Psoriasis.
    Qi C; Wang Y; Li P; Zhao J
    Front Immunol; 2021; 12():627139. PubMed ID: 33732249
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.